CA1075604A - Pharmaceutical spasmolytic composition - Google Patents

Pharmaceutical spasmolytic composition

Info

Publication number
CA1075604A
CA1075604A CA278,449A CA278449A CA1075604A CA 1075604 A CA1075604 A CA 1075604A CA 278449 A CA278449 A CA 278449A CA 1075604 A CA1075604 A CA 1075604A
Authority
CA
Canada
Prior art keywords
composition
allyl
compound
acid
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA278,449A
Other languages
English (en)
French (fr)
Inventor
Rolf Deininger
Erich Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chimicasa GmbH
Original Assignee
Chimicasa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chimicasa GmbH filed Critical Chimicasa GmbH
Application granted granted Critical
Publication of CA1075604A publication Critical patent/CA1075604A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C07C69/01—Vinyl esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/16—Acetic acid esters of dihydroxylic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA278,449A 1976-05-18 1977-05-16 Pharmaceutical spasmolytic composition Expired CA1075604A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU74973A LU74973A1 (US20100012521A1-20100121-C00001.png) 1976-05-18 1976-05-18

Publications (1)

Publication Number Publication Date
CA1075604A true CA1075604A (en) 1980-04-15

Family

ID=19728242

Family Applications (1)

Application Number Title Priority Date Filing Date
CA278,449A Expired CA1075604A (en) 1976-05-18 1977-05-16 Pharmaceutical spasmolytic composition

Country Status (9)

Country Link
JP (1) JPS52142030A (US20100012521A1-20100121-C00001.png)
BE (1) BE854716A (US20100012521A1-20100121-C00001.png)
CA (1) CA1075604A (US20100012521A1-20100121-C00001.png)
DE (1) DE2719623A1 (US20100012521A1-20100121-C00001.png)
ES (1) ES458893A1 (US20100012521A1-20100121-C00001.png)
FR (1) FR2362625A1 (US20100012521A1-20100121-C00001.png)
GB (1) GB1572119A (US20100012521A1-20100121-C00001.png)
LU (1) LU74973A1 (US20100012521A1-20100121-C00001.png)
NL (1) NL7705436A (US20100012521A1-20100121-C00001.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466458A1 (fr) * 1979-09-27 1981-04-10 Mathieu Andre Nouveaux medicaments derives de l'eugenol
US4533746A (en) * 1983-06-16 1985-08-06 International Flavors & Fragrances Inc. 2-Methoxy-4-(2-methylpropenyl) phenyl ester of isobutyric acid, flavor use thereof and process for preparing same

Also Published As

Publication number Publication date
FR2362625A1 (fr) 1978-03-24
DE2719623A1 (de) 1977-12-08
FR2362625B1 (US20100012521A1-20100121-C00001.png) 1980-01-18
BE854716A (fr) 1977-09-16
JPS52142030A (en) 1977-11-26
GB1572119A (en) 1980-07-23
NL7705436A (nl) 1977-11-22
ES458893A1 (es) 1978-03-16
LU74973A1 (US20100012521A1-20100121-C00001.png) 1977-12-22

Similar Documents

Publication Publication Date Title
CA1239587A (en) Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPH0154339B2 (US20100012521A1-20100121-C00001.png)
JPH0456840B2 (US20100012521A1-20100121-C00001.png)
DE2527937A1 (de) Benzcycloamidderivate und verfahren zu ihrer herstellung sowie pharmazeutische mittel, worin sie enthalten sind
JPH07508000A (ja) １，２，３−トリアゾール及びイミダゾール化合物並びにそれらの抗腫瘍用途
TNSN91049A1 (fr) Benzimidazoles substitues, procedes en vue de leur preparation, et leur emploi pharmaceutique
DE3686168T2 (de) Hydroxyphenylthioalkylketoalkohole.
FUJITA et al. Antitumor activity of acylated oridonin
IE44639B1 (en) Oxadiazoloyl-substituted compounds having pharmacological activity
CA1075604A (en) Pharmaceutical spasmolytic composition
BE898524A (fr) Analogues d'amino-prostaglandines à substituant 7-oxabicycloheptane, ayant des propriétés thérapeutiques.
US4119730A (en) Treating muscle spasms
AU2003209616B2 (en) Bicyclic CB2 cannabinoid receptor ligands
DE2558502C2 (US20100012521A1-20100121-C00001.png)
US4540709A (en) Method for treatment of diseases mediated by PAF using 5-allyl-2-(3,4-Dimethoxyphenyl)-3a,α-methoxy-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran
US4053624A (en) Indole-2-carbaldehyde compounds and blood sugar reducing compositions
DE1618849B1 (de) Phenylisopropylamidverbindungen und Verfahren zu ihrer Herstellung
US3143469A (en) Anti-cholesterol nicotinic acid nu-oxide
US4758591A (en) Dialkanoyloxybenzylidene dialkanoate
US4520029A (en) Farnesene derivatives, mucosal stabilizing compositions and method of manufacturing the same
US6071898A (en) Asiatic acid derivatives having modified A-ring
US4647412A (en) Anti-tumor derivatives of butanediol and process of preparation
US4423073A (en) Fluorinated diaminopentene derivatives
US3646067A (en) Adamantylaminophenoxypropanols and ester derivatives
Gualtieri et al. Cyclopentane analog of muscarone

Legal Events

Date Code Title Description
MKEX Expiry